Treatment FAQ

what is a phase based treatment study called

by Dr. Lilliana Macejkovic Published 3 years ago Updated 2 years ago
image

Full Answer

What is the study phase of clinical trials?

This study phase is the definitive trial for a drug’s effectiveness, because it compares the drug’s performance with that of the current standard treatment. Researchers can use placebos during this phase when there is no standard treatment.

What is a Phase I study?

Phase I studies are done to find the highest dose of the new treatment that can be given safely without causing severe side effects. Although the treatment has been tested in lab and animal studies, the side effects in people can’t be known for sure. These studies also help to decide on the best way to give the new treatment.

What is the difference between Phase 1 and phase 0 clinical trials?

The biggest difference between phase 0 and the later phases of clinical trials is that there’s almost no chance the volunteer will benefit by taking part in a phase 0 trial – the benefit will be for other people in the future. Because drug doses are low, there’s also less risk to the patient in phase 0 studies compared to phase I studies.

What is a Phase 2 study in drug development?

Phase 2: In Phase 2 studies, researchers administer the drug to a larger group of patients (typically up to a few hundred) with the disease or condition for which the drug is being developed to initially assess its effectiveness and to further study its safety. A key focus of Phase 2 studies is determining the optimal dose or doses ...

image

What are the 3 types of clinical trials?

Types of clinical trialsInterventional trials aim to find out more about a particular intervention, or treatment. ... Observational studies aim to find out what happens to people in different situations. ... Feasibility studies are designed to see if it is possible to do the main study.More items...•

What is a phase study?

Phase I studies of a new drug are usually the first that involve people. Phase I studies are done to find the highest dose of the new treatment that can be given safely without causing severe side effects.

What are Phase III studies usually called?

Researchers design Phase 3 studies to demonstrate whether or not a product offers a treatment benefit to a specific population. Sometimes known as pivotal studies, these studies involve 300 to 3,000 participants.

Which study is phase of clinical trial?

There are 3 main phases of clinical trials – phases 1 to 3. Phase 1 trials are the earliest phase trials and phase 3 are later phase trials. Some trials have an earlier stage called phase 0, and there are some phase 4 trials done after a drug has been licensed.

What are the 4 phases of research?

Research is a dynamic process that can be organized into four stages: Exploring, Investigating, Processing, and Creating. As you work through a research project, you may move back and forth between these stages as your understanding evolves.

What do phases mean in clinical trials?

Phase I trials test if a new treatment is safe and look for the best way to give the treatment. Doctors also look for signs that cancer responds to the new treatment. Phase II trials test if one type of cancer responds to the new treatment. Phase III trials test if a new treatment is better than a standard treatment.

What is a synonym description for the Phase 4 trials?

The phase 4 trial is also referred to as post marketing surveillance and as the name suggests, it is conducted after the drug is already marketed and available to the general public.

What type of studies may be conducted during Phase 4?

Other phase IV studies could be RCTs, in vitro studies, outcomes research (burden of illness) and pharmacoeconomic studies, drug utilization studies, practical clinical trials, and investigator-initiated research in practice.

What is a Phase 2 study?

A study that tests whether a new treatment works for a certain type of cancer or other disease (for example, whether it shrinks a tumor or improves blood test results).

What is CDM in clinical research?

Clinical Data Management (CDM) is a critical phase in clinical research, which leads to generation of high-quality, reliable, and statistically sound data from clinical trials. This helps to produce a drastic reduction in time from drug development to marketing.

Which phase of a clinical trial refers to a study designed to determine the effects of the drug or device on humans including how it is absorbed metabolized and excreted?

Phase II clinical trials test both the safety and effectiveness of a drug or medical device. Trials in this stage can last from several months to a few years, and recruit up to several hundred patients with the condition to take part.

What is a pivotal study FDA?

What is a pivotal clinical trial? A pivotal clinical trial is a clinical study seeking to demonstrate the efficacy of a new drug in order to obtain its marketing approval by regulatory authorities (e.g. FDA in the United States and EMA in Europe).

Phase 0 Clinical Trials: Exploring If and How A New Drug May Work

Even though phase 0 studies are done in humans, this type of study isn’t like the other phases of clinical trials. The purpose of this phase is to...

Phase I Clinical Trials: Is The Treatment Safe?

Phase I studies of a new drug are usually the first that involve people. The main reason for doing phase I studies is to find the highest dose of t...

Phase II Clinical Trials: Does The Treatment Work?

If a new treatment is found to be reasonably safe in phase I clinical trials, it can then be tested in a phase II clinical trial to find out if it...

Phase III Clinical Trials: Is It Better Than What’S Already available?

Treatments that have been shown to work in phase II studies usually must succeed in one more phase of testing before they’re approved for general u...

Submission For FDA Approval: New Drug Application (NDA)

In the United States, when phase III clinical trials (or sometimes phase II studies) show a new drug is more effective and/or safer than the curren...

Phase IV Clinical Trials: What Else Do We Need to Know?

Drugs approved by the FDA are often watched over a long period of time in phase IV studies. Even after testing a new medicine on thousands of peopl...

What is the phase of clinical trials?

Clinical trials follow a rigorous series from early, small-scale, Phase 1 studies to late-stage, large scale, Phase 3 studies. If a treatment is successful in one phase, it moves on to the next phase. A successful clinical trial process continues until the developer files a marketing application with the U.S.

What is phase 1 in a drug study?

In addition to safety, researchers can answer other questions in a Phase 1 trial related to how much drug is measured in the blood after administration, how the drug works in the body and the side effects associated with increased dosage. Phase 2: In Phase 2 studies, researchers administer the drug to a larger group of patients ...

What is phase 2 in medicine?

Phase 2: In Phase 2 studies, researchers administer the drug to a larger group of patients (typically up to a few hundred) with the disease or condition for which the drug is being developed to initially assess its effectiveness and to further study its safety. A key focus of Phase 2 studies is determining the optimal dose or doses ...

What is a phase 3 NDA?

Because Phase 3 trial results often provide the basis for approval, Phase 3 trials are sometimes also called pivotal trials.

What is clinical research?

The term “clinical trials” or “clinical research” refers to studies that are conducted in people. Researchers design clinical trials to answer specific research questions related to a drug candidate. Clinical trials follow a rigorous series from early, small-scale, Phase 1 studies to late-stage, large scale, Phase 3 studies.

What is the focus of Phase 2?

A key focus of Phase 2 studies is determining the optimal dose or doses of a drug candidate, in order to determine how best to administer the drug to maximize possible benefits, while minimizing risks. Phase 3:

How many volunteers are in phase 1?

In most cases, 20 to 80 healthy volunteers participate in Phase 1. The primary purpose of a Phase 1 study is to evaluate the safety of a new drug candidate before it proceeds to further clinical studies.

What is phase 1 clinical trial?

Phase 1 clinical trials are usually the first to involve people, and help doctors learn if a new treatment is safe. Most often, the treatment is administered to a small group of healthy individuals, with the primary goal of testing for any major side-effects and safety issues, as well as determining the ideal dose.

What is the purpose of each phase of a clinical trial?

Each phase helps answer different questions about the new treatment. While the treatment’s safety and efficacy is monitored throughout each phase, the phase that a clinical trial is in roughly represents how much is known about the treatment that’s being studied. The phase that a clinical trial is in can be a factor to consider when finding ...

How long does a phase 2 trial last?

Phase 2 trials usually last over the course of several months to two years, and often new combinations of drugs are tested. Although phase 2 clinical trials observe a bigger participant group than in ...

What does it mean when a cancer patient is on a clinical trial?

For example, in a cancer clinical trial, it may mean the cancer disappears completely, or that patients on the new treatment live longer than they would have been expected to without the treatment. In other studies, especially for chronic conditions, the benefit may be an improved quality of life.

How many participants are in a phase 1 trial?

Phase 1 clinical trials last from several months to a year, and usually have 10 to 80 participants. All information gathered from the phase 1 clinical trial helps researchers design the phase 2 study. Approximately 70% of drugs move on to phase 2 trials, according to the FDA.

What is a phase 3 drug application?

When phase 3 clinical trials (or sometimes phase 2 trials) show a new drug is more effective and safer than the current standard treatment, a New Drug Application (NDA) is submitted to the Food and Drug Administration (FDA) for approval. The NDA, which includes data from all the pre-clinical and clinical studies, is reviewed by the FDA.

Why do doctors randomly assign patients to study groups?

This helps them to see if the new treatment works better than the standard treatment, if it has fewer side effects, or both. Because doctors don't know which treatment is better yet , study participants are often assigned to the groups randomly, and neither the doctors nor patients know which treatment they're on.

What are the phases of a drug study?

Phase II studies are sometimes divided into Phase IIa and Phase IIb. There is no formal definition for these two sub-categories, but generally: 1 Phase IIa studies are usually pilot studies designed to demonstrate clinical efficacy or biological activity ('proof of concept' studies); 2 Phase IIb studies determine the optimal dose at which the drug shows biological activity with minimal side-effects (‘definite dose-finding’ studies).

How many phases are there in clinical trials?

The drug development process will normally proceed through all four phases over many years. If the drug successfully passes through Phases I , II, and III, it will usually be approved by the national regulatory authority for use in the general population. Phase IV trials are 'post-marketing' or 'surveillance' studies conducted to monitor safety over several years.

What is phase 1 in animal testing?

The tested range of doses will usually be a fraction of the dose that caused harm in animal testing.

What is phase IIA?

Phase IIa studies are usually pilot studies designed to demonstrate clinical efficacy or biological activity ( 'proof of concept' studies); Phase IIb studies determine the optimal dose at which the drug shows biological activity with minimal side-effects (‘definite dose-finding’ studies).

What is a preclinical test?

Before clinical trials are undertaken for a candidate drug, vaccine, medical device, or diagnostic assay, the product candidate is tested extensively in preclinical studies. Such studies involve in vitro ( test tube or cell culture) and in vivo ( animal model) experiments using wide-ranging doses of the study agent to obtain preliminary efficacy, toxicity and pharmacokinetic information. Such tests assist the developer to decide whether a drug candidate has scientific merit for further development as an investigational new drug.

What is phase 3 in medicine?

This phase is designed to assess the effectiveness of the new intervention and, thereby, its value in clinical practice. Phase III studies are randomized controlled multicenter trials on large patient groups (300–3,000 or more depending upon the disease/medical condition studied) and are aimed at being the definitive assessment of how effective the drug is, in comparison with current 'gold standard' treatment. Because of their size and comparatively long duration, Phase III trials are the most expensive, time-consuming and difficult trials to design and run, especially in therapies for chronic medical conditions. Phase III trials of chronic conditions or diseases often have a short follow-up period for evaluation, relative to the period of time the intervention might be used in practice. This is sometimes called the "pre-marketing phase" because it actually measures consumer response to the drug.

How much does a phase II study cost?

The amount of money spent on Phase II/III trials depends on numerous factors, with therapeutic area being studied and types of clinical procedures as key drivers; Phase II studies may cost as much as $20 million, and Phase III as much as $53 million.

What is phase 2 testing?

Phase II: Testing uses a larger group of patients, all with a specific condition or disease. The intent: “to get information about how effective the drug is to treat certain parameters of that disease,” McLaughlin says. That helps researchers determine how well a medication or treatment works in response.

What is clinical trial?

Clinical trials follow strict procedure to achieve their goals and ensure that everyone involved is safely monitored throughout.

How long does it take for a drug to be approved for phase 3?

The average time between filing for approval in phase III to receiving it from the FDA is 1.6 years, with cancer drugs having the shortest approval time (about 1.1 years), and neurological drugs having the longest approval time (about two years). Phase III clinical trials can cost as much as $53 million.

What is clinical trial?

A clinical trial phase is one of the stages of testing that a new intervention, whether a drug, treatment, or device, goes through to become available for legal use. These phases normally consist of phase I through phase IV, but can also include a phase 0.

What is clinical research?

Clinical trials are a type of clinical research that where researchers study specific illnesses and the safety and effectiveness of new interventions (such as drugs, treatments, diagnostic mechanisms, or devices).

What is the goal of cancer clinical trials?

In some cancer clinical trials, the goal is remission, which means that there are no more cancer cells detectable in the body. The research process leading up to clinical trials often includes animals ( in vivo studies) and extensive laboratory work ( in vitro studies ).

Why are medical device trials unique?

Medical device clinical trials are unique because they are smaller in scale overall and require less phases. Medical device studies are more difficult to blind, randomize, and control. Many are dependent on physician’s technique, and device modifications usually happen during the trial.

Why do researchers design clinical trials?

Researchers design a clinical trial to follow a specific study plan or protocol. This helps them answer specific research questions about their studies’ intervention. A well-designed study plan helps secure funding, ethics approvals, regulatory approvals, and any needed development approvals.

What are the two types of interventional studies?

There are two types of interventional studies: controlled (or comparative) studies and open-label studies.

Abstract

The treatment of posttraumatic stress disorder (PTSD) related to a history of sexual and/or physical abuse in childhood is the subject of international debate, with some favouring a phase-based approach as their preferred treatment, while others argue for immediate trauma-focused treatment.

Background

For posttraumatic stress disorder (PTSD), international expert consensus guidelines recommend the use of evidence-based, trauma-focused psychological treatments, particularly cognitive behavioural therapy (i.e., prolonged exposure) and eye movement desensitization and reprocessing (EMDR) therapy [ 1, 2 ].

Discussion

There is debate about the treatment of PTSD related to physical and/or sexual abuse during childhood.

Trial status

The second protocol version was finished in May 2016. Trial enrolment started on 5 September 2017 and recruitment is ongoing as of 31 December 2018 Additional file 1.

Author information

Department for Anxiety and Mood Disorders, Dimence Mental Health Group, Deventer, the Netherlands

Ethics declarations

This study was ethically approved by the Institutional Review Board of Twente, reference number P16–03. We will obtain signed informed consent from all participating patients.

Additional file

SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documents. (PDF 132 kb)

How long does phase 3 of a clinical trial last?

Trials in this phase can last for several years. The purpose of phase III is to evaluate how the new medication works in comparison to existing medications for the same condition.

Why do we need a phase 3 trial?

This helps to eliminate bias when interpreting results. The FDA usually requires a phase III clinical trial before approving a new medication. Due to the larger number of participants and longer duration or phase III, rare and long-term side effects are more likely to show up during this phase. If investigators demonstrate ...

Why do investigators use a very small dose of medication?

Investigators use a very small dose of medication to make sure it isn’t harmful to humans before they start using it in higher doses for later phases . If the medication acts differently than expected, the investigators will likely to do some additional preclinical research before deciding whether to continue the trial.

What do investigators do before conducting clinical trials?

Before doing a clinical trial, investigators conduct preclinical research using human cell cultures or animal models. For example, they might test whether a new medication is toxic to a small sample of human cells in a laboratory.

What happens in phase 2?

What happens in phase II? Phase II of a clinical trial involves several hundred participants who are living with the condition that the new medication is meant to treat. They’re usually given the same dose that was found to be safe in the previous phase.

How many people are in phase 1 of a clinical trial?

During phase I of a clinical trial, investigators spend several months looking at the effects of the medication on about 20 to 80 people who have no underlying health conditions. This phase aims to figure out the highest dose humans can take without serious side effects.

What is clinical trial?

Clinical trials are a way to test new methods of diagnosing, treating, or preventing health conditions. The goal is to determine whether something is both safe and effective. A variety of things are evaluated through clinical trials, including: medications. medication combinations.

What is systematic review?

A summary of the clinical literature. A systematic review is a critical assessment and evaluation of all research studies that address a particular clinical issue. The researchers use an organized method of locating, assembling, and evaluating a body of literature on a particular topic using a set of specific criteria.

What is cohort study?

Cohort Study (Prospective Observational Study) A clinical research study in which people who presently have a certain condition or receive a particular treatment are followed over time and compared with another group of people who are not affected by the condition.

What is a controlled trial?

A controlled clinical trial that randomly (by chance) assigns participants to two or more groups. There are various methods to randomize study participants to their groups. Example : Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial .

What is qualitative research?

Qualitative Studies - Research that derives data from observation, interviews, or verbal interactions and focuses on the meanings and interpretations of the participants. Quantitative Studies - Quantitative research is research that uses numerical analysis.

What is the application of longitudinal studies?

Longitudinal Studies - Studies in which variables relating to an individual or group of individuals are assessed over a period of time.

Is there prejudice in case control studies?

There is no sense of prejudice or subjectivity implied in the assessment of bias under these conditions. Case Control Studies - Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease.

image

Overview

The phases of clinical research are the stages in which scientists conduct experiments with a health intervention to obtain sufficient evidence for a process considered effective as a medical treatment. For drug development, the clinical phases start with testing for safety in a few human subjects, then expand to many study participants (potentially tens of thousands) to determine if the treatment is effective. Clinical research is conducted on drug candidates, vaccine candidates…

Summary

Clinical trials testing potential medical products are commonly classified into four phases. The drug development process will normally proceed through all four phases over many years. If the drug successfully passes through Phases I, II, and III, it will usually be approved by the national regulatory authority for use in the general population. Phase IV trials are 'post-marketing' or 'surveillance' studies conducted to monitor safety over several years.

Preclinical studies

Before clinical trials are undertaken for a candidate drug, vaccine, medical device, or diagnostic assay, the product candidate is tested extensively in preclinical studies. Such studies involve in vitro (test tube or cell culture) and in vivo (animal model) experiments using wide-ranging doses of the study agent to obtain preliminary efficacy, toxicity and pharmacokinetic information. Such tests assist the developer to decide whether a drug candidate has scientific merit for further develop…

Phase 0

Phase 0 is a recent designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Phase 0 trials are also known as human microdosing studies and are designed to speed up the development of promising drugs or imaging agents by establishing very early on whether the drug or agent behaves in human subjects as was expected from preclinical …

Phase I

Phase I trials were formerly referred to as “first-in-man studies” but the field generally moved to the gender-neutral language phrase "first-in-humans" in the 1990s; these trials are the first stage of testing in human subjects. They are designed to test the safety, side effects, best dose, and formulation method for the drug. Phase I trials are not randomized, and thus are vulnerable to selection bias.

Phase II

Once a dose or range of doses is determined, the next goal is to evaluate whether the drug has any biological activity or effect. Phase II trials are performed on larger groups (50–300) and are designed to assess how well the drug works, as well as to continue Phase I safety assessments in a larger group of volunteers and patients. Genetic testing is common, particularly when there is evidence of variation in metabolic rate. When the development process for a new drug fails, this …

Phase III

This phase is designed to assess the effectiveness of the new intervention and, thereby, its value in clinical practice. Phase III studies are randomized controlled multicenter trials on large patient groups (300–3,000 or more depending upon the disease/medical condition studied) and are aimed at being the definitive assessment of how effective the drug is, in comparison with current 'gold standard' treatment. Because of their size and comparatively long duration, Phase III trials …

Phase IV

A Phase IV trial is also known as a postmarketing surveillance trial or drug monitoring trial to assure long-term safety and effectiveness of the drug, vaccine, device or diagnostic test. Phase IV trials involve the safety surveillance (pharmacovigilance) and ongoing technical support of a drug after it receives regulatory approval to be sold. Phase IV studies may be required by regulatory authorities or may be undertaken by the sponsoring company for competitive (finding a new mar…

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9